The figure 25.3 % surpasses: Tirzepatide SURMOUNT-1: 22.5 % Semaglutide STEP-1: 14.9 % Retatrutide Phase 2: 24.2 % (comparable, but Phase 3 results for Retatrutide are still lacking) It raises the question whether CagriSema will be the first molecule with an effect truly comparable to bariatric surgery (typically 2530 % reduction)
Agwunobi AO, Bancewicz J, Attwood SE
It neutralizes free radicals, reduces oxidative stress at the cellular level, and inhibits tyrosinase, the enzyme that drives melanin production
Vitamin-B12-independent methionine synthase from a higher plant ( Catharanthus roseus )
Clin Pediatr Endocrinol 20:3338 Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelins effects on food intake